Patient Perceptions of Wearable and Smartphone Technologies for Remote Outcome Monitoring in Total Knee Arthroplasties.

Autor:	Kurtz SM; Department of Biomedical Engineering, Exponent, Inc., Philadelphia, Pennyslvania.; Implant Research Core, Drexel University, Philadelphia, Pennyslvania., Higgs GB; Department of Biomedical Engineering, Exponent, Inc., Menlo Park, California., Chen Z; Sinai Hospital of Baltimore, Rubin Institute for Advanced Orthopedics, Baltimore, Maryland.; Department of Orthopaedics, Northwell Health-Lenox Hill Hospital, New York, New York., Koshut WJ; Department of Biomedical Engineering, Exponent, Inc., Menlo Park, California., Tarazi JM; Department of Orthopaedics, Northwell Health-Huntington Hospital, Huntington, New York.; Donald and Barbara Zucker School of Medicine at Hofstra, Northwell, Hempstead, New York, New York., Sherman AE; Department of Orthopaedics, Northwell Health-Lenox Hill Hospital, New York, New York., McLean SG; Department of Biomedical Engineering, Exponent, Inc., Menlo Park, California., Mont MA; Sinai Hospital of Baltimore, Rubin Institute for Advanced Orthopedics, Baltimore, Maryland.; Department of Orthopaedics, Northwell Health-Lenox Hill Hospital, New York, New York.
Jazyk:	angličtina
Zdroj:	The journal of knee surgery [J Knee Surg] 2023 Oct; Vol. 36 (12), pp. 1253-1258. Date of Electronic Publication: 2022 Sep 01.
DOI:	10.1055/s-0042-1755378
Abstrakt:	While there is enthusiasm for wearables and smartphone technologies in evaluating clinical outcomes among clinicians, less is known about the willingness of patients who have osteoarthritis (OA) to consent for remote outcome monitoring. We developed an Institutional Review Board-approved questionnaire to assess patient perceptions of remote monitoring technologies in a high-volume orthopaedic clinical center. Fifty total knee arthroplasty (TKA) patients (56% female; mean age: 61 years, range: 23-89) and fifty nonoperative OA knee patients (54% female; mean age: 58 years, range: 25-89) routinely consulted in the clinic as part of their OA treatment and consented to participate in the study. Patient perceptions were compared using Pearson's chi-square analyses with a significance threshold of p  < 0.05. We found that TKA patients were more receptive to the use of smartphone apps (84 vs. 60%, p  = 0.008) and wearable sensors (80 vs. 48%, p  < 0.001) and learning to use custom wearables (72 vs. 38%, p  = 0.002) than nonoperative OA knee patients as part of their treatment. Likewise, the majority of TKA patients were willing to use the global positioning system in their postoperative technology (54 vs. 18%, p  < 0.001), especially if they were only active during certain circumstances (62 vs. 24%, p  < 0.001). TKA patients also expressed willingness to have their body movement (68%), balance (70%), sleep (76%), and cardiac output (80%) tracked using remote technologies. Overall, we found that TKA patients were highly receptive to using wearable technology in their treatments, whereas nonoperative OA knee patients were generally unreceptive. Our study challenges the concept that current wearable technology approaches will be generally effective as a tool to remotely monitor all patients across the OA severity landscape. Competing Interests: M.A.M. reports grants from 3M, Centrexion, CERAS Health, Flexion Therapeutics, Johnson & Johnson, Kolon Tissuegene, Mirror-AR, NXSCI, Pacira, Peerwell, Pfizer-Lily, Skye Biologics, SOLVD Health, Smith & Nephew, Stryker, US Medical Innovations, other from Stryker, other from Journal of Arthroplasty, Journal of Knee Surgery, Surgical Technology International, Orthopaedics, other from The Hip Society, The Knee Society, outside the submitted work.W.J.K. reports other from Exponent, Inc., outside the submitted work.G.B.H. reports other from Exponent, Inc., outside the submitted work.S.M.K. reports grants from Ferring Pharmaceuticals, during the conduct of the study; grants from Stryker, Zimmer Biomet, Invibio, Wright Medical Technology, Ceramtec, Celanese, Ferring Pharmaceuticals, Formae, Lima Corporate, SINTX Technologies, Orthoplastics, Osteal Therapeutics, 3Spine, DePuy Synthes, and other from Exponent, Inc., outside the submitted work. (Thieme. All rights reserved.)
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu